ASCO Registry Data Dashboard Provides Insights on Patients with Cancer and COVID-19

November 9, 2020

The American Society of Clinical Oncology (ASCO) Survey on COVID-19 in Oncology Registry (ASCO Registry) recently launched a new, interactive data dashboard, which summarizes the demographic and cancer information of patients included in the ASCO Registry.

The ASCO Registry, which launched in April 2020, aims to help the entire cancer community learn about the pattern of symptoms and severity of COVID-19 among patients with cancer, as well as how SARS-CoV-2 viral infections impact the delivery of cancer care and patient outcomes. As of November 6, the Registry includes data from 39 oncology practices in the United States and 701 patients. The Registry includes a combination of practices that are within health systems and independent medical oncology practices.

While the ASCO Registry collects both baseline and follow-up patient data, the new dashboard provides data specifically about patient information at the time of their COVID-19 diagnosis. Types of data include:

  • Demographic data, like age, gender, race, and ethnicity
  • Health history, including body mass index, smoking status, and comorbidities
  • Cancer history, including type and severity of cancer, as well as cancer treatment at the time of COVID-19 diagnosis

Researchers, oncologists, patients, and others interested in the impact of COVID-19 on patients with cancer can use the interactive dashboard to see what risk factors seem to be more common in patients with cancer and COVID-19. For example, clicking on “Hypertension - Yes” will show that it is a risk factor for 46% of male patients in the Registry. The dashboard can also be used to see the specific types of cancer therapy patients were receiving at the time of their COVID-19 diagnosis. In addition, oncologists may want to use the dashboard to learn how their patient population compares to those entered in the Registry.

The dashboard will be updated weekly as new data arrives from practices participating in the ASCO Registry. ASCO intends to roll out additional features in early 2021, following release of the initial scientific manuscript.

Learn more about the ASCO Registry, including how to enroll.